RECURRENT OVARIAN CANCER
Clinical trials for RECURRENT OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARIAN CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study aims to keep ovarian cancer drug from hurting eyes
Disease control Recruiting nowThis study is for people with recurrent ovarian cancer whose tumors have a high level of a protein called FRα. The drug mirvetuximab soravtansine can cause eye problems, so researchers are testing different eye drops to see if they can prevent or reduce these side effects. About …
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 26, 2026 10:04 UTC
-
New hope for hard-to-treat ovarian cancer: experimental combo targets resistant tumors
Disease control Recruiting nowThis study tests whether adding an experimental drug called CapsuleX to the chemo drug cisplatin can shrink tumors in people with ovarian cancer that no longer responds to platinum-based treatments. About 40 adults with recurrent ovarian, fallopian tube, or primary peritoneal can…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New antibody combo aims to shrink hard-to-treat ovarian tumors
Disease control Recruiting nowThis early-phase trial tests an experimental drug called ubamatamab, alone or with another drug (cemiplimab), in people with ovarian or uterine cancer that has come back. The main goals are to check safety, find the best dose, and see if the treatment can shrink tumors. About 890…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Ancient herb meets modern medicine: ashwagandha trial for ovarian cancer
Disease control Recruiting nowThis study tests whether adding Ashwagandha (an herbal supplement) to standard chemotherapy (DOXIL) is safe and effective for people with ovarian cancer that has returned after initial treatment. About 72 participants will first help find the best Ashwagandha dose, then researche…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sham Sunder Kakar • Aim: Disease control
Last updated May 18, 2026 12:06 UTC